Medical Device News Magazine

Vein Specialist Antonios Gasparis Joins Northwell Health

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Antonios Gasparis, MD

Renowned vascular surgeon/vein specialist Antonios Gasparis, MD, has joined Northwell Health as the new System Chief for Venous Disease. Known for developing world-class vein programs, Dr. Gasparis looks to increase access to care and expand treatment options to patients across the health system, bringing this level of care close to home. He comes to Northwell from Stony Brook University Hospital.

Career

Over his career, Dr. Antonios Gasparis has published and presented on hundreds of topics and received numerous academic honors and awards for his research. He has served as president of the American Venous Forum – the leading international society in venous and lymphatic disease – and founded and co-directed several educational programs including the Venous Symposium, one of the world’s largest venous meetings.

Northwell CEO Said

“I’m honored to welcome Dr. Antonios Gasparis to the Northwell Health family,” said Michael Dowling, Northwell’s president and CEO. “Dr. Gasparis has decades of unparalleled experience in the field of venous disease and we’re so excited for him to bring that knowledge to Northwell. Working together, we’ll be able to treat more patients across the state with this condition and bring a better quality of life to these patients than ever before.”

Vein disease is common across the country, affecting about 40 percent of the population. Dr. Gasparis will work to develop vein centers across Northwell’s multiple hospitals and satellite locations. He will also be standardizing venous treatments across Northwell and increasing patient access to treatment for venous disease.

Dr. Gasparis, with his extensive experience with new technology, will be able to bring cutting-edge, minimally invasive procedures to Northwell. Northwell is about to be one of two centers in the United States and the first in New York to participate in a clinical trial that will use high-intensity focused ultrasound, known as HIFU, to treat varicose veins. The treatment will allow patients to receive completely non-invasive varicose vein treatment for the first time.

To Create a Venous Program

“Creating a venous program like this, at the scale that Northwell provides, is something I’ve wanted to do for at least a decade,” said Dr. Antonios Gasparis. “I’m really blessed that I can make a difference for people suffering from venous disease. Venous disease encompasses a range of conditions that can be debilitating. We’re building a program that tackles them all, from the most common to the most complex.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”